Turning Cancer Patients and Caregivers Into Informed Decision- Makers 

 

Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today.  Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen? 

Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care.  Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.

Welcome!


Check out our latest blog posts:


Myeloma Cancer Coaching-Antineoplaston Therapy for Refractory Myeloma
"Yes, I am still in CR from my refractory MM and have been since I completed ANP therapy in 4/99.[...]
Lasix Side Effects-Is Furosemide Necessary for Stable Heart Failure?
Lasix reduces fluid yet also causes a host of side effects. The study linked below questions the need for Lasix[...]
Pancreatic Cancer-Pharmacologic Ascorbic Acid, Curcumin, Bitter Melon?
The patient survived nearly 4 years after diagnosis (pancreatic cancer), with PAA as his sole treatment, and he achieved objective[...]
Myeloma Survivor- Got Chemobrain? Get Aromatherapy, Essential Oils
"Clinical trials have examined (essential oils) use in patients with cancer (multiple myeloma) for anxiety, nausea, vomiting and other health-related[...]
Is a Diagnosis of “Plasma Cell Dyscrasia” a Diagnosis of MGUS, SMM or MM?
"Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in[...]
Multiple Myeloma-Non-Toxic Venous Thromboembolism (VTE) Risk Reduction
“With an aging population and a rising prevalence of obesity and cancer (MM), the incidence of VTE is expected to[...]